Sharma A, Singh P, Chauhan R, Panda I, Devana S, Bora G
Indian J Urol. 2024; 40(2):127-132.
PMID: 38725894
PMC: 11078449.
DOI: 10.4103/iju.iju_324_23.
Sundi D, Collier K, Yang Y, Diaz D, Pohar K, Singer E
Cancers (Basel). 2024; 16(4).
PMID: 38398136
PMC: 10886823.
DOI: 10.3390/cancers16040746.
Chuang K, Chiou S, Hsu S
Cancers (Basel). 2023; 15(13).
PMID: 37444447
PMC: 10340346.
DOI: 10.3390/cancers15133338.
Lindner A, Lackner F, Tymoszuk P, Barth D, Seeber A, Kocher F
Biol Sex Differ. 2023; 14(1):38.
PMID: 37277835
PMC: 10243034.
DOI: 10.1186/s13293-023-00522-x.
Chen J, Huang C, Quan C, Zu X, Ou Z, Tsai Y
Nat Rev Urol. 2023; 20(9):560-574.
PMID: 37072491
DOI: 10.1038/s41585-023-00761-y.
Programmed death ligand 1 regulates epithelial-mesenchymal transition and cancer stem cell phenotypes in hepatocellular carcinoma through the serum and glucocorticoid kinase 2/β-catenin signaling pathway.
Kong X, Peng H, Liu P, Fu X, Wang N, Zhang D
Cancer Sci. 2023; 114(6):2265-2276.
PMID: 36751987
PMC: 10236605.
DOI: 10.1111/cas.15753.
Mechanism of Sex Differences in Bladder Cancer: Evident and Elusive Sex-biasing Factors.
Lam C, Li Z, Theodorescu D, Li X
Bladder Cancer. 2022; 8(3):241-254.
PMID: 36277328
PMC: 9536425.
DOI: 10.3233/BLC-211658.
Impact of sex on outcomes after surgery for non-muscle-invasive and muscle-invasive bladder urothelial carcinoma: a systematic review and meta-analysis.
Mori K, Yanagisawa T, Katayama S, Laukhtina E, Pradere B, Mostafaei H
World J Urol. 2022; 41(4):909-919.
PMID: 35963957
PMC: 10159976.
DOI: 10.1007/s00345-022-04116-x.
Targeting the androgen receptor to enhance NK cell killing efficacy in bladder cancer by modulating ADAR2/circ_0001005/PD-L1 signaling.
Liu Q, You B, Meng J, Huang C, Dong G, Wang R
Cancer Gene Ther. 2022; 29(12):1988-2000.
PMID: 35915245
PMC: 9750871.
DOI: 10.1038/s41417-022-00506-w.
The carbonic anhydrase inhibitor acetazolamide inhibits urinary bladder cancers via suppression of β-catenin signaling.
Matsue T, Gi M, Shiota M, Tachibana H, Suzuki S, Fujioka M
Cancer Sci. 2022; 113(8):2642-2653.
PMID: 35723039
PMC: 9357660.
DOI: 10.1111/cas.15467.
The prognostic role of steroid hormone receptor signaling pathways in urothelial carcinoma.
Nagata Y, Miyamoto H
Transl Cancer Res. 2022; 9(10):6596-6608.
PMID: 35117270
PMC: 8798270.
DOI: 10.21037/tcr.2020.01.06.
Androgen Receptor as an Emerging Feasible Biomarker for Breast Cancer.
You C, Leung M, Tsang W, Khoo U, Tsoi H
Biomolecules. 2022; 12(1).
PMID: 35053220
PMC: 8774219.
DOI: 10.3390/biom12010072.
Low Expression of EphB2, EphB3, and EphB4 in Bladder Cancer: Novel Potential Indicators of Muscular Invasion.
Lee T, Heo J, Jeong J, Lee G, Park D, Kim T
Yonsei Med J. 2021; 62(8):679-690.
PMID: 34296545
PMC: 8298868.
DOI: 10.3349/ymj.2021.62.8.679.
Sex Hormone Receptor Signaling in Bladder Cancer: A Potential Target for Enhancing the Efficacy of Conventional Non-Surgical Therapy.
Ide H, Miyamoto H
Cells. 2021; 10(5).
PMID: 34064926
PMC: 8150801.
DOI: 10.3390/cells10051169.
Cryptotanshinone, a novel PDK 4 inhibitor, suppresses bladder cancer cell invasiveness via the mTOR/β‑catenin/N‑cadherin axis.
Kim C, Terado T, Tambe Y, Mukaisho K, Kageyama S, Kawauchi A
Int J Oncol. 2021; 59(1).
PMID: 33982789
PMC: 8131085.
DOI: 10.3892/ijo.2021.5220.
Identification of low-frequency variants of UGT1A3 associated with bladder cancer risk by next-generation sequencing.
Zheng R, Du M, Ge Y, Gao F, Xin J, Lv Q
Oncogene. 2021; 40(13):2382-2394.
PMID: 33658628
PMC: 8016664.
DOI: 10.1038/s41388-021-01672-1.
Editorial: The Androgen Receptor in Breast Cancer.
Tesei A, Castoria G
Front Endocrinol (Lausanne). 2021; 11:636480.
PMID: 33519718
PMC: 7844589.
DOI: 10.3389/fendo.2020.636480.
Implications of androgen receptor and FUS expression on tumor progression in urothelial carcinoma.
Mohamed Abd Raboh N, Hakim S, Abd El Atti R
Histol Histopathol. 2020; 36(3):325-337.
PMID: 33354760
DOI: 10.14670/HH-18-295.
PIK3CA Is Regulated by CUX1, Promotes Cell Growth and Metastasis in Bladder Cancer Activating Epithelial-Mesenchymal Transition.
Wang Z, Shang J, Li Z, Li H, Zhang C, He K
Front Oncol. 2020; 10:536072.
PMID: 33344221
PMC: 7744743.
DOI: 10.3389/fonc.2020.536072.
Predictive value of β-catenin in bladder cancer: a systematic review and meta-analysis.
Ren J, Yang Y, Peng T, Xu D
Biosci Rep. 2020; 40(9).
PMID: 32797169
PMC: 7475297.
DOI: 10.1042/BSR20202127.